Diabetes Academy...“Diabetes Academy - What’s new in diabetes” is an important clinical update...
2
“Diabetes Academy - What’s new in diabetes” is an important clinical update discussing the key treatment for diabetes. The course is intended to increase the knowledge and confidence of clinicians caring for people with diabetes. This e-learning course provides an evidence-based update for clinicians on the novel medications and emerging technologies available to improve outcomes in people with diabetes. Clinical case studies using video vignettes and multiple-choice questions are designed to optimise comprehension and learning. The course is suitable for clinicians working in the field of diabetes, including GPs, physician trainees, practice nurses, diabetes nurse educators, general physicians, pharmacists and medical students. Learning outcomes • Understand and discuss the indications and benefits of novel medications in diabetes management including GLP1 analogues, SGLT2 inhibitors, DPPIV inhibitors. • In-depth knowledge and practical understanding of novel technologies in diabetes including insulin pumps and continuous glucose monitoring. • Describe the current guidelines and management of gestational diabetes. • Develop a framework for the management of hypertension and dyslipidemia in diabetes. Diabetes Academy What’s new in diabetes Recognition Certificate of Completion issued upon course completion. Convenience Fully online. Study on iOS, Android and Windows devices or on web browsers. Reinforcement 9 interactive tutorials and 22 online cases to practise interpretation.
Transcript of Diabetes Academy...“Diabetes Academy - What’s new in diabetes” is an important clinical update...
“Diabetes Academy - What’s new in diabetes” is an important
clinical update discussing the key treatment for diabetes. The
course is intended to increase the knowledge and confidence of
clinicians caring for people with diabetes.
This e-learning course provides an evidence-based update for clinicians on the novel medications and emerging technologies available to improve outcomes in people with diabetes. Clinical case studies using video vignettes and multiple-choice questions are designed to optimise comprehension and learning.
The course is suitable for clinicians working in the field of diabetes, including GPs, physician trainees, practice nurses, diabetes nurse educators, general physicians, pharmacists and medical students.
Learning outcomes
• Understand and discuss the indications and benefits of novel medications in diabetes management including GLP1 analogues, SGLT2 inhibitors, DPPIV inhibitors.
• In-depth knowledge and practical understanding of novel technologies in diabetes including insulin pumps and continuous glucose monitoring.
• Describe the current guidelines and management of gestational diabetes.
• Develop a framework for the management of hypertension and dyslipidemia in diabetes.
Diabetes AcademyWhat’s new in diabetes
RecognitionCertificate of Completion issued upon course completion.
ConvenienceFully online. Study on iOS, Android and Windows devices or on web browsers.
Reinforcement9 interactive tutorials and 22 online cases to practise interpretation.
Delivery Mode
Students have the flexibility to study in their own time and location. Program materials can be accessed through the eLearning Education app on phones or tablet devices with iOS, Android or Windows systems. Program materials can also be accessed online using a web browser.
Assessment
• Submission of all tutorial self-assessments
• Submission of all case studies
Course Duration
It is estimated that this course takes 12 hours to complete. It is recommended that you complete the course within one month to optimise your learning experience.
Fees
A$500
A$250 student discount (Please attach screenshot of student enrolment upon application)
Contact Us
Mobile Learning Unit
T +61 3 8344 5673 E [email protected]
How to Apply
Visit the UoM Diabetes Academy webpage to apply
Course Outline
This course is comprised of 9 interactive tutorials and 22 case studies –
• Essentials of Diabetes Care
• GLP1 Analogues
• SGLT2 Inhibitors
• DPPIV Inhibitors
• Update on Insulin Pump Therapy
• Update on Continuous Glucose Monitoring
• Diabetes in Pregnancy
• Diabetes and Hypertension
• Hyperlipidemia in Diabetes
